Wednesday, July 8, 2026

pharma · COVID-19 · Poliomyelitis

Sinovac Research and

Sinovac Research and clinical programs — 11 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Dhaka, CN HQ
2022 Founded
9 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Dhaka, CN
Founded
2022
Employees
9
Programs
115
Drugs
54
Patents
0
Intelligence · Clinical Programs

Sinovac Research and projects

11 ClinicalTrials.gov programs sponsored by Sinovac Research and.

Sinovac Research and has 11 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. 100U inactivated Enterovirus Type 71 Vaccine

    Sinovac Research and Development Co.,

    Hand-foot-mouth Disease

    phase 1 mab completed

    1 trial
  2. Inactivated Enterovirus Type 71 Vaccine

    Sinovac Research and Development Co.,

    Infection; Viral, Enterovirus

    phase 1 mab completed

    1 trial
  3. Investigational 13-valent Pneumococcal Polysaccharide Conjugate Vaccine

    Sinovac Research and Development Co.,

    Pneumococcal Infections

    phase 1 mab completed

    1 trial
  4. Low-dose RSV mRNA vaccine

    Sinovac Research and Development Co.,

    RSV

    phase 1 mab active

    1 trial
  5. One dose of investigational vaccine

    Sinovac Research and Development Co.,

    Hepatitis B

    phase 1 mab completed

    1 trial
  6. PRO-PanFlu-1001

    Sinovac Research and Development Co.,

    Influenza

    phase 1 mab completed

    1 trial
  7. SA55 Injection

    Sinovac Research and Development Co.,

    COVID-19

    phase 1 small molecule active

    1 trial
  8. SA55 nasal spray

    Sinovac Research and Development Co.,

    COVID-19

    phase 1 small molecule active

    1 trial
  9. Sinovac PCV24 formulation 1

    Sinovac Research and Development Co.,

    Pneumococcal Infectious Disease

    phase 1 mab completed

    2 trials
  10. high-dose Group ACYW135X Meningococcal Conjugate Vaccine

    Sinovac Research and Development Co.,

    Meningococcal Meningitis

    phase 1 mab active

    1 trial
  11. pandemic influenza vaccine (H5N1 strain NIBRG-14)

    Sinovac Research and Development Co.,

    Pandemic Influenza Vaccine

    phase 1 mab completed

    1 trial

Frequently asked questions

How many clinical projects does Sinovac Research and have?

11 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.